Fludarabine and mitoxantrone for the refractory relapse treatment of B-cell low-grade non-Hodgkin lymphoma (NHL):: LACOHG first interim report (Latin American Cooperative Oncology Hematology Group).

被引：0
|
作者：
Baltazar-Arellano, Severiano
Pimentel, Patricia
Vera, Luis
Bezares, Fernando
Malaga, Jose
Huamani-Z, Julia
Montante, Antonio
Rivas-Vera, Silvia
Carrasco-Yalan, Antonio A.
Beltran-Garate, Brady E.
机构：
[1] Ctr Med Noreste, Monterrey, Mexico
[2] Hosp Edgardo Rebagliati Martins, Dept Hematol Oncol, Lima, Peru
[3] Hosp Alvarez, Dept Hematol, Buenos Aires, DF, Argentina
[4] Hosp Natl Del Sur, Dept Hematol, Arequipa, Peru
[5] Hosp Gen Mexico OD, Mexico City, DF, Mexico
[6] Inst Nacl Cancerol, Mexico City, DF, Mexico
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4665
引用
收藏
页码：247B / 248B
页数：2
相关论文
共 50 条
  • [21] MINIMAL DISSEMINATED DISEASE/RESIDUAL DISEASE IN CHILDREN AND ADOLESCENTS WITH MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL) MAY IMPACT THE RISK OF RELAPSE: A CHILDREN'S ONCOLOGY GROUP REPORT
    Shiramizu, B.
    Goldman, S.
    Smith, L.
    Harrison, L.
    Van De Ven, C.
    Gross, T. G.
    Sanger, W.
    Perkins, S.
    Cairo, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 : 114 - 114
  • [22] Repeated radioimmunotherapy (RIT) with 131I-rituximab for patients with low grade and aggressive relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye Jin
    Lee, Seung-Sook
    Kim, Kyeong Min
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] Carbamazepine-induced hypersensitivity syndrome and low grade B-cell non-Hodgkin lymphoma: a case report
    Plavsic, A.
    Tomic-Spiric, V
    Raskovic, S.
    Stefanovic, L.
    Arandjelovic, S.
    Peric-Popadic, A.
    Durutovic, D.
    Bogic, M.
    ALLERGY, 2011, 66 : 375 - 375
  • [24] Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: A report from Chinese multi-center cooperative group
    Tang, JY
    Pan, C
    Chen, J
    Chen, HJ
    Wu, Y
    Xue, HL
    Zhao, HJ
    Gu, LJ
    Fu, RY
    Wang, YP
    MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (03): : 212 - 214
  • [25] In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma
    Shamash, J
    Salam, AH
    Davies, DC
    Williams, A
    Joel, S
    Lister, TA
    BRITISH JOURNAL OF CANCER, 1998, 77 (10) : 1598 - 1603
  • [26] Rituxan plus GM-CSF for the treatment of low grade follicular (B cell) non-Hodgkin's lymphoma (NHL).
    Janakiraman, N
    Gautam, S
    Xu, Y
    Fortney, C
    Green, J
    van derVeen, M
    Looney, S
    Carey, JL
    BLOOD, 2001, 98 (11) : 243B - 243B
  • [27] In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma
    J Shamash
    AH Salam
    DC Davies
    A Williams
    S Joel
    TA Lister
    British Journal of Cancer, 1998, 77 : 1598 - 1603
  • [28] Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
    Kaminski, MS
    Zelenetz, AD
    Press, OW
    Saleh, M
    Leonard, J
    Fehrenbacher, L
    Lister, TA
    Stagg, RJ
    Tidmarsh, GF
    Kroll, S
    Wahl, RL
    Knox, SJ
    Vose, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3918 - 3928
  • [29] A multicenter phase II study of iodine-131 anti-B1 antibody (Bexxar) in patients (pts) with chemotherapy-relapsed/refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphoma (NHL)
    Kaminski, MS
    Vose, J
    Saleh, M
    Lister, A
    Knox, S
    Crowther, D
    Zelenetz, AD
    Colcher, D
    Wahl, R
    BLOOD, 1997, 90 (10) : 2268 - 2268
  • [30] Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14)
    Itoh, Kuniaki
    Igarashi, Tadahiko
    Irisawa, Hiroyuki
    Aotsuka, Nobuyuki
    Masuda, Shinichi
    Utsu, Yoshikazu
    Tsujimura, Hideki
    Tsukasaki, Kunihiro
    Wakita, Hisashi
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1606 - 1613
12345